FSMA

TechnipFMC Announces Results and Upsizing of Note Tender Offer

Friday, December 3, 2021 - 12:16am

The Company further announced that it has increased the maximum aggregate principal amount of Notes to be accepted in the Tender Offer (the Maximum Tender Amount) from $100 million to $200 million.

Key Points: 
  • The Company further announced that it has increased the maximum aggregate principal amount of Notes to be accepted in the Tender Offer (the Maximum Tender Amount) from $100 million to $200 million.
  • The terms and conditions of the Tender Offer, as set forth in the offer to purchase (the Offer to Purchase), dated November 18, 2021, otherwise remain unchanged.
  • The Company has engaged BofA Securities, Inc. and Citigroup Global Markets, Inc., to act as the dealer managers for the Tender Offer.
  • The Tender Offer is being made solely pursuant to the terms of the Offer to Purchase.

DGAP-News: European Healthcare Acquisition & Growth Company B.V.: Former German healthcare leader of McKinsey & Company, Thomas Rudolph, takes office

Wednesday, December 1, 2021 - 2:25pm

There has been no, and will not be, public offering of the securities in the United States.

Key Points: 
  • There has been no, and will not be, public offering of the securities in the United States.
  • The Securities of EHC have not been, and will not be, registered under the Securities Act.
  • This publication constitutes neither an offer to sell nor a solicitation to buy securities.
  • The listing of the securities has been made solely by the means of, and on the basis of, the Prospectus.

Rimini BidCo Announces Pricing of €445 Million Floating Rate Sustainability-Linked Senior Secured Notes due 2026

Tuesday, November 30, 2021 - 10:59pm

The Notes priced at an issue price of 98.5% and will bear interest at a rate equal to three-month EURIBOR (with a 0.0% floor), plus 5.25% per annum, reset quarterly.

Key Points: 
  • The Notes priced at an issue price of 98.5% and will bear interest at a rate equal to three-month EURIBOR (with a 0.0% floor), plus 5.25% per annum, reset quarterly.
  • The Offering is expected to close on December 14, 2021, subject to customary closing conditions, and the Notes will mature on December 14, 2026.
  • This press release is neither an offer to sell nor the solicitation of an offer to purchase any security.
  • This press release is being issued pursuant to, and in accordance with, Rule 135c under the Securities Act.

Société du Grand Paris : final terms serie 17 Issue of EUR 1,250,000,000 1.000 per cent. Notes due 26 November 2051

Thursday, November 25, 2021 - 2:04pm

Socit du Grand Paris : final terms serie 17 Issue of EUR 1,250,000,000 1.000 per cent.

Key Points: 
  • Socit du Grand Paris : final terms serie 17 Issue of EUR 1,250,000,000 1.000 per cent.
  • Notes due 26 November 2051
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • This document constitutes the Final Terms of the Notes described herein for the purposes of the Prospectus Regulation and must be read in conjunction with such Base Prospectus.
  • The Final Terms and the Base Prospectus will be available on the Issuer's website ( https://www.societedugrandparis.fr/publications-financieres-1870 ) and on the AMF's website ( www.amf-france.org ).

Société du Grand Paris : Final terms - Issue of EUR 1,750,000,000 0.300 per cent. Notes due 25 November 2031

Thursday, November 25, 2021 - 2:04pm

Socit du Grand Paris : Final terms - Issue of EUR 1,750,000,000 0.300 per cent.

Key Points: 
  • Socit du Grand Paris : Final terms - Issue of EUR 1,750,000,000 0.300 per cent.
  • Notes due 25 November 2031
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • This document constitutes the Final Terms of the Notes described herein for the purposes of the Prospectus Regulation and must be read in conjunction with such Base Prospectus.
  • The Final Terms and the Base Prospectus will be available on the Issuer's website ( https://www.societedugrandparis.fr/publications-financieres-1870 ) and on the AMF's website ( www.amf-france.org ).

Global X ETFs Launches Copper Miners UCITS ETF (COPX) as the Firm’s First Commodity-Focused Fund in Europe

Wednesday, November 24, 2021 - 10:00am

London, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Global X ETFs, a leading global provider of exchange-traded funds (ETFs), today announced the launch of the Global X Copper Miners UCITS ETF (COPX) on London Stock Exchange and Deutsche Brse Xetra.

Key Points: 
  • London, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Global X ETFs, a leading global provider of exchange-traded funds (ETFs), today announced the launch of the Global X Copper Miners UCITS ETF (COPX) on London Stock Exchange and Deutsche Brse Xetra.
  • The fund will be Global Xs first commodity-focused UCITS ETF to launch in Europe, adding to the firms growing UCITS product line-up.
  • Leveraging our expertise in commodities ETFs in the U.S. market, Global X is thrilled to provide European investors a targeted play on copper mining stocks with COPX.
  • The fund tracks the Solactive Global Copper Miners v2 index and will join Global Xs existing lineup of 12 UCITS ETFs in the European market.

MDxHealth Shareholder Transparency Declarations

Monday, November 22, 2021 - 10:00pm

MDxHealth was notified that the number of shares with respect to which Soleus Capital Management, L.P. can exercise voting rights actively crossed below the threshold of 3% of the outstanding shares and voting rights of MDxHealth on 16 November 2021.

Key Points: 
  • MDxHealth was notified that the number of shares with respect to which Soleus Capital Management, L.P. can exercise voting rights actively crossed below the threshold of 3% of the outstanding shares and voting rights of MDxHealth on 16 November 2021.
  • Notably, it follows from the notification that the previously reported shares of MDxHealth were held through Soleus Capital Master Fund, L.P., a limited partnership formed in the Cayman Islands.
  • MDxHealth was notified that the number of shares with respect to which Bleichroeder LP can exercise voting rights actively crossed above the threshold of 15% of the outstanding shares and voting rights of MDxHealth on 19 November 2021.
  • The MDxHealth logo, MDxHealth, ConfirmMDx and SelectMDx are trademarks or registered trademarks of MDxHealth SA.

DGAP-News: High-profile sponsor team completes EUR 200 million private placement for first-of-its-kind novel acquisition and growth company in the European healthcare sector

Monday, November 22, 2021 - 7:21pm

The Securities of the Company have not been, and will not be, registered under the Securities Act.

Key Points: 
  • The Securities of the Company have not been, and will not be, registered under the Securities Act.
  • This publication constitutes neither an offer to sell nor a solicitation to buy securities.
  • The listing of the securities will be made solely by the means of, and on the basis of, the Prospectus which is yet to be published.
  • An investment decision regarding any securities of European Healthcare Acquisition & Growth Company B.V. should only be made on the basis of the Prospectus.

Global X ETFs Continues European Growth with the Launch of an Additional Seven Thematic UCITS ETFs

Thursday, November 18, 2021 - 2:47pm

Digital transformation of the global economy continues to be a major driver of change throughout the value chain, challenging traditional investment frameworks.

Key Points: 
  • Digital transformation of the global economy continues to be a major driver of change throughout the value chain, challenging traditional investment frameworks.
  • The Global X CleanTech UCITS ETF (CTEK) tracks the Indxx Global CleanTech v2 Index.
  • The Global X E-commerce UCITS ETF (EBIZ) provides exposures to companies positioned to benefit from any increased adoption of E-commerce as a distribution model.
  • The Global X FinTech UCITS ETF (FINX), which follows the Indxx Global FinTech Thematic v2 Index, strives to invest in companies on the leading edge of the emerging financial technology sector.

TechnipFMC Commences Tender Offer For Up To $100 Million Principal Amount of Notes

Friday, November 19, 2021 - 3:30am

Holders of 2023 Notes must tender their 2023 Notes by the 2023 Notes Offer Expiration Time to be eligible to receive the Total Consideration.

Key Points: 
  • Holders of 2023 Notes must tender their 2023 Notes by the 2023 Notes Offer Expiration Time to be eligible to receive the Total Consideration.
  • For the 2023 Notes, the Tender Offer will expire at 4:00 P.M., Paris time, on December 2, 2021 (in respect of such Notes, the 2023 Notes Offer Expiration Time), unless extended or earlier terminated.
  • No tenders of 2023 Notes will be accepted after the 2023 Notes Offer Expiration Time whether or not the Maximum Tender Amount is exceeded.
  • Holders of 2025 Notes and 2026 Notes who validly tender their Notes after the Early Tender Time will only be eligible to receive the Tender Offer Consideration, which is the Total Consideration less the Early Tender Premium.